Induction of chondroitin sulfate proteoglycan synthesis and secretion in lymphocytes and monocytes by unknown
Induction 
Secretion 
of Chondroitin  Sulfate Proteoglycan 
in Lymphocytes and Monocytes 
Synthesis and 
DANIEL  LEVITT and PEI-LEE HO 
Department of Pediatrics, University of Chicago, and La Rabida Children's Hospital and Research Center, 
Chicago, Illinois 60649 
ABSTRACT  The  ability  of  mononuclear  leukocytes  to  synthesize  and  secrete  proteoglycans 
was evaluated.  Using radiolabeling with H2 35SO4, it is shown that peripheral blood  mononu- 
clear cells (PBMC) and their major subpopulations (B cells, T cells, and monocytes), as well as 
mouse spleen cells,  all  secreted  easily  detectable  proteoglycan.  After 24-h labeling  periods, 
90% of macromolecular  3ss could  be detected  in culture  media. This material was primarily 
(>95%) chondroitin-4-sulfate  proteoglycan (CSPG). Production  and secretion of CSPG could 
be stimulated more than 200% in PBMC and 300% in T cell populations by high concentrations 
of concanavalin  A  and  phorbol  12-myristate-13-acetate;  lipopolysaccharide  induced  a small 
(twofold) but reproducible  increase  in CSPG secretion by adherent mononuclear leukocytes. 
The CSPG secreted  by  PBMC was relatively  small  in  size  compared  to  chondrocyte  CSPG 
(130,000  daltons  vs.  2-4  million  daltons)  but  possessed similar  sizes of glycosaminoglycan 
chains and  greater solubility  in  low ionic  strength  solutions.  This sulfated  polyanion,  which 
was produced endogenously by leukocytes and was actively secreted, might function as a co- 
mediator or "second messenger" in certain immune responses. 
Sulfated  proteoglycans (PG) ~ are  complex macromolecules 
consisting of polysaccharide chains containing uronic acid (D- 
glucuronic  or  L-iduronic  acids)  and  N-acetylamino  sugars 
covalently linked to a protein core (1, 2). The best character- 
ized PG are the chondroitin sulfate proteoglycans (CSPG) of 
cartilage. These molecules usually form large, matrix-bound 
aggregates with hyaluronic acid and link protein (3-5). 
Chondroitin sulfate proteoglycan has been isolated from a 
large number of cells and tissues other than  cartilage,  is a 
major component of virtually all connective tissues, and is 
synthesized by many nonconnective  tissue  cells (6-17).  In 
some instances,  CSPG isolated from noncartilage cells can 
form macro-aggregates with hyaluronic acid, and may even 
share  core protein  antigenic  identities with  cartilage CSPG 
(18-20). 
The potential to produce chondroitin sulfate (CS) exists in 
virtually all cells. Either D-xylose or/3-D-xylosides can substi- 
tute for both the  core protein  and  first xylose residue and 
~Abbreviations  used  in  this paper:  Con  A,  concanavalin  A;  CS, 
chondroitin sulfate; CSPG, chondroitin sulfate proteoglycan; A Di- 
OS, disaccharide o-sulfate; A Di-4S, disaccharide 4-sulfate; A Di-6S, 
disaccharide 6-sulfate; GAG, glycosaminoglycan;  LPS, E. coli 055:BS 
lipopolysaccharide; PBMC, peripheral blood mononuclear cells; Vo, 
void volume; V~, total volume. 
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permit  cells  to  express their  biosynthetic  potential  for CS 
chain production in the absence of core protein (21-25). Cells 
producing minimal quantities  of CSPG appear to  lack the 
capacity for translating a core protein acceptor but do possess 
the  multienzyme glycosyl transferase complexes capable of 
creating CS  chains  linked  to  xyloside acceptors.  These  CS 
chains are shorter than CS chains linked to core protein (24). 
It has also been demonstrated that CSPG produced by non- 
cartilage cells is smaller than cartilage CSPG (26).  In some 
instances,  only  1-2  CS  chains  (compared  with  25-40  in 
cartilage) are linked to core protein, yielding PG with molec- 
ular weights between 70,000 and 170,000  daltons (18). 
Although sulfated proteoglycans can be produced by several 
types of cells, the function(s) of these macromolecules, apart 
from  their  structural  roles  in  connective  tissues,  are  still 
unclear. Low molecular weight chondroitin 4-sulfate isolated 
from human serum inhibits the hemolytic activity of Clq (27). 
Alterations in CSPG content and metabolism occur during 
distinct stages of organogenesis and may effect cell migration 
and tissue morphology (28). 
The immune system is composed of networks of interacting 
cells and molecules where specific humoral or cellular func- 
tions can  be easily analyzed.  While the effects of cartilage 
proteoglycans on immune responses have not been well char- 
351 acterized (29,  30),  it is apparent that certain sulfated poly- 
anions can exert significant influences on immune responses 
(31,  32) and may even alter hematopoiesis (33).  Since non- 
cartilage cells can synthesize PG, it seemed possible to us that 
polyanions endogenously produced by leukocytes themselves 
might act as intermediaries in the regulation of various im- 
mune responses. As the first step towards analyzing potential 
effects of PG on the immune system, we evaluated its presence 
in white blood cells. We report here that low molecular weight 
CSPG are ubiquitously synthesized and secreted by normal 
human and  mouse lymphocytes and  monocytes. More im- 
portant, T lymphocytes, the major immunoregulatory cells in 
mammals,  can  be  selectively  stimulated  by  specific com- 
pounds to increase their synthesis and secretion of CSPG. 
MATERIALS  AND  METHODS 
Materials 
RPMI-1640  and pokeweed  mitogen  (PWM) were purchased  from Gibco 
Laboratories (Grand Island, NY), fetal bovine serum from K. C. Bioiogicals, 
Inc. (Lanexa, KA), concanavalin  A (Con  A), aminoethylisothiouronium  bro- 
mide (AET), nonspecific protease, soy bean trypsin  inhibitor,  phenylmethyl- 
sulfonyl fluoride (PMSF), e-aminocaproic  acid and phorbol  12-myristate  13- 
acetate (TPA) from Sigma Chemical Co. (St. Louis, MO), phytohemagglutinin 
M (PHA-M), and Escherichia coli 055:B5 lipopolysaccharide (LPS) from Difco 
Laboratories  (Detroit,  MI), sheep erythrocytes  from Flow Laboratories  (Mc- 
Lean,  VA), H2 3sSO4 (43 Ci/mg)  and thymidine  (methyl-3H) (6.7 Ci/mmol) 
from New  England  Nuclear  (Boston,  MA), Sepharosc  6B,  Scphacryl  S-200, 
Sephadex G-50,  G-10  and Ficoll-isopaque  from Pharmacia  Fine  Chemicals 
(Piscataway, N  J), bovine testicular hyaluronidase from Leo (Helsingborg, Swe- 
den), chondroitinase  AC II, chondroitinase  ABC, and standard  disaccharides 
(A Di-OS, A Di-4S and A Di-6S) from Miles Laboratories (Elkhart, IN). BALB/ 
c  mice  were  purchased  from Cumberland View Farms (Clinton,  TN)  and 
Jackson Laboratories (Bar Harbor,  ME). 
Cell Lines 
Cell lines were derived from peripheral blood cells of normal, immunodefi- 
cient, and autoimmune individuals and individuals with lymphoid  malignan- 
cies by infecting B cells with Epstein-Barr virus (34). The 7-0Z/3  mouse cell 
line and  its subclones  70Z/3.1.4  and 4.1. were obtained  from Dr.  Michael 
Loken (University of Chicago). Cell lines were cultured  in RPMI-1640 media 
containing  10% fetal bovine serum, 5 x  l0  -5 M 2-mercaptoethanol,  2 mM L- 
glutamine,  100 U/ml penicillin, and 100/~g/ml streptomycin (complete media). 
Cells were fed every 2-3 d by splitting 1:4 with complete medium. 
Separation of Peripheral Blood Mononuclear 
Cell Fractions 
Radiolabeling of Sulfated Proteoglycans and DNA 
Cells were cultured  in complete media containing  different concentrations 
of mitogen (dose ranges of mitogens: (a) Con A: l-100 ~g/ml; (b) LPS: 5-100 
~g/ml; (c) pwm:  1/100-1/800  (vol/vol); (d) PHA:  1-100 tal/ml; (e) Staphylo- 
coccus aureus Cowans I (SA): 1:1,000-1:20,000 (vol/vol); (f) TPA: 0.5-25  ng/ 
ml) and 25 uCi/ml H2 3sSO4 for 24-120  h. In some experiments, 24 h before 
harvest 5 ~Ci/ml  [~H]thymidine were added  to duplicate  cultures to analyze 
for DNA synthesis. Cells were harvested onto glass fiber filters using a multiple 
automated  sample  harvester  (Flow Laboratories,  McLean,  VA); filters were 
dried and counted in a Packard 3000 TriCarb Liquid Scintillation Counter. 
Analysis of Proteoglycans 
M E D IA:  Radiolabeled-culture  medium was dialyzed against  20  liters of 
H20,  then lyophilized. The sample was dissolved in 0.05 M sodium acetate 
buffer, pH 6.8, containing  either 0.15  M  Nacl or 4 M guanidine  HCI plus 
proteolytic inhibitors PMSF (2 mM), e-aminocaproic acid ( 1 mM), and soybean 
trypsin inhibitor (1  mg/ml). To determine  the size of intact PG, samples were 
chromatographed  on a  1.5 cm x  50 cm column of Sepharose 6B or a  1 cmx 
85 cm column of Scphacryl S-200 or Sephadex G-50 equilibrated with 0.05 M 
sodium  acetate  buffer,  pH  6.8, plus 0.15 M  Nacl.  Radioactivity  in  l-ml 
fractions was determined  by liquid scintillation counting. 
CELLS:  After washing with 0.15 M NaCI, cells were lyscd with borate- 
saline buffer, pH 8.2  containing  0.02 M  KCI, 0.5% Na deoxycholate,  0.5% 
Nonidet P-40, 0.1% NAN3, and proteolytic inhibitors for 30 rain on ice. Debris 
was sedimented  for  10  min at  10,000 g  and the supernatant was dialyzed 
against 20 1  of H20, then treated the same as the culture media. 
Quantitation and Analysis of 
Sulfated Glycosaminoglgcans 
Incorporation  of H23~SO4 into glycosaminoglycans was determined  for both 
media and cell lysates. After dialysis against H20 and lyophilization,  material 
from media and cells was resuspended  in phosphate-buffered  saline (pH 7.4) 
and digested with 1.5 mg/ml of autodigested protease for 3 h at 37"C. Glycos- 
aminoglycans were isolated from digests using  10%  cetylpyridinium  chloride 
(39),  and  radioactivity  was  measured  by liquid  scintillation  counting.  The 
capacity of cells to produce sulfated glycosaminoglycan chains was determined 
using 4-methylumbeUiferyl-~-D-xyloside  as previously described (22). 
The size of  sulfated glycosaminoglycans was analyzed after their release from 
core protein  using 0.5  N NaOH for 18  h at room temperature.  After being 
neutralized with 6 N HCL, the digests were chromatographed  on Sepharose 6B 
or Scphacryl S-200 and the size of labeled material was calculated according to 
Wasteson (40). 
The percentage of chondroitin  sulfate in each  sample was determined  by 
digestion  of sulfate-labeled  material  larger  than  the  total  volume  Vt  with 
chondroitinase  ABC or AC II to distinguish  between chondroitin  4- and 6- 
sulfate and dermatan sulfate.  The percentage  of heparan  sulfate  in culture 
media was analyzed after  treating  the samples with  nitrous acid (41-42).  In 
both  instances,  released or  digested  3~S-labeled material  was  analyzed  on 
Scphadex G-50 columns eluted with 0.15 M NaC1. 
Heparinized  venous blood obtained  from normal volunteers was separated 
on  Ficoll-hypaque  cushions  (35). Monocytes  were depleted  from peripheral 
blood mononuclear  cells (PBMC) with Sephadex G- 10 (36). Monocyte-enriched 
cells (70-80%  nonspecific esterase positive) were obtained  by washing the G- 
10 beads with 100% fetal bovine serum at 4°C for 60 min. 
To separate B cell-enriched fractions from T cells, monocyte-depleted PBMC 
were incubated  with AET-treated  sheep erythrocytes (37). The B cell fraction 
contained  50-60%  surface Ig  + cells,  15-25% esterase positive cells,  10-25% 
null cells, and 3-6% OKT3  + cells. The T cell fraction possessed 95-98% T cells 
determined  by immunofluorescent  staining with the  monoclonal  pan T  cell 
reagent OKT3 (38). 
Analysis of 4- Vs. 6-Sulfation 
Sulfate-labeled material derived from culture media or cell lysates of PBMC 
or spleen cells was initially separated on Scphadex G-50. Radioactivity migrat- 
ing in the void volume Vo was digested with chondroitinase  AC, then rechro- 
matographed  on Sephadex G-50. Counts isolated in the V, were concentrated 
by lyophilization,  then separated  by descending  paper chromatography  (43) 
using standard disaccharides to determine distances of migration. Radioactivity 
was eluted from serially sliced 2-cm x 2-cm pieces of paper using 0.15 M NaCI, 
then counted. In some instances, chromatograms  were exposed to Kodak XAR 
x-ray film to determine  the migration patterns of released disaccharides. 
Isolation of Mouse Spleen Cells 
Spleens were removed  from adult  (3-6  mo) BALB/c female  mice,  then 
dissociated into single cell suspensions using sterile frosted glass slides or wire 
mesh (Cellector, Bellco Glass Co., Vineland, NJ). Erythrocytes were hypotoni- 
cally lysed and debris was removed by filtering cells through nylon mesh. Spleen 
cells prepared  in this manner were >92% viable (determined  by exclusion of 
0.2% trypan blue dye) and contained an average of 45% surface ig  + B cells and 
35%  thy  1.2 + T  cells by fluorescence microscopy  and  10%  esterase-positive 
macrophages. 
RESULTS 
Synthesis of PG and Sulfated Glycosaminoglycan 
(GAG) by Lymphoblastoid Lines 
To assess whether lymphoid cells could produce proteogly- 
cans, cell lines possessing phenotypic similarities with normal 
B  cells at various stages of development were  radiolabeled 
with H2 35SO4, and relative quantities of PG were measured. 
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sulfated PG (Table I).  <10%  of incorporated 35S remained 
cell-associated after the 24-h labeling period. The capability 
of  each cell line to produce sulfated glycosaminoglycan chains 
was explored by adding the galactose acceptor 4-methylum- 
belliferyl-/3-o-xyloside  to replace core protein (22-25). Lym- 
phoblastoid lines could increase synthesis of GAG 1.4-5-fold 
above endogenous levels (Table I), confirming the substantial 
biosynthetic potential for sulfated polysaccharides present in 
each B cell line. 
Interestingly, the mouse "pre-B" cell line 70Z/3  also se- 
creted sulfated proteoglycans (Table II). Two clones of 70Z/ 
3, 70Z/3.1.4, and 70Z/3.4.1  were labeled with H2 35SO4 for 
24 h in the presence or absence of LPS. LPS induces surface 
IgM expression in 70Z/3.1.4 cells, but not in 70Z/3.4.1 cells. 
Three- to fivefold increases in 3sS incorporation occurred in 
the presence of LPS inboth cell lines, while increased GAG 
secretion in  the  presence  of/3-D-xyloside was  consistently 
greater for the 70Z/3.4. l cell line. Thus, synthesis and secre- 
tion  of PG  did  not correlate with  induction of surface Ig 
expression in these cell lines. 
Normal Lymphocytes Secrete PG 
Since lymphoblastoid cell lines produced sulfated PG, we 
determined whether normal lymphocytes produced and se- 
creted  these  macromolecules.  Both  total  peripheral  blood 
TABLE  I 
Secretion of Sulfated Proteoglycans by Human Lymphoblastoid 
Cell Lines 
CPM ass secreted/106 cultured cells* 
Cell line*  Unstimulated  With xyloside 
LBW-8  630  1,230 
Nalm-6  2,500  10,940 
Daudi  4,300  7,130 
DB  18,545  78,253 
F4  8,150  44,120 
LBW-17  13,580  18,140 
Stern  12,430  N D 
LBW-25  11,471  26,895 
* Cell lines were loosely classified according to B cell phenotype as: LBW-8: 
null; Nalm-6: pre-B; Daudi, DB, F4: B lymphoblast; LBW-17, Stern, LBW-25: 
plasmacyte. 
* Nondialyzable, water-soluble radioactivity was isolated from culture media 
after 24-h incubation with  10 #Ci/ml  H2 3sso4 as described in Materials 
and Methods. For xyloside stimulation,  104 M 4-methylumbelliferyl-~-o- 
xyloside was added at the initiation of culture. Specific activities of H235SO4 
used for labeling were the same in all experiments and were corrected for 
radioactive decay. 
TABLE  II 
Stimulation of Proteoglycan Secretion by LPS in 70Z/3 Mouse 
Cell Lines 
CPM asS secreted/10  6 
cultured cells* 
Cell line*  LPS*  Unstimulated  With xyloside 
70Z/3.1.4  -  1,680  3,520 
+  6,860  9,140 
70Z/3.4.1  -  1,520  2,790 
+  5,230  13,930 
* 70Z/3.1.4  can be induced to express surface IgMk with LPS. 70Z/3.4.1  is 
unable to express surface IgM after LPS stimulation. 
* 25 ~.g/ml. 
i See *, Table I. 
TABLE III 
Cell-associated and Secreted Sulfated PG Produced by Human 
PBMC Populations 
Exp.  CPM S~S/10  6 cells* 
no.  PBMC  B cells  T cells  Monocytes 
1  Cells  2,305  1,115  2,005  3,210 
Media  27,700  35,270  21,500  32,250 
2  Cells  1,900  870  1,875  3,220 
Media  20,805  16,360  25,620  26,210 
3  Cells  2,290  1,630  1,325  3,800 
Media  30,805  15,000  21,820  19,520 
* Cultures were incubated for 4 d in media containing 25/~Ci/ml  H2 3sSO4. 
Media were removed and dialyzed against 20 1  of H20. Cells were washed, 
then  lysed. Debris was sedimented at 10,000 g and the supernatant was 
dialyzed against H20.  Results are expressed as sulfate incorporation  into 
nondialyzable water-soluble material per 106 cultured cells. 
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FIGURE  1  Migration  of  proteoglycans  isolated  from  media  of 
mononuclear  leukocyte  cultures  on  Sephacryl  S-200.  Sulfate-la- 
beled proteoglycans were separated on 1-cm x  85-cm columns of 
Sephacryl S-200.  Large molecular weight material (0)  was treated 
with  0.5  N  NaOH  and  rechromatographed on  the  same column 
(O). Vo, void volume; Vt, total volume. 
mononuclear cells and mononuclear cell subpopulations se- 
creted easily detectable sulfated PG (Table III,  see below). 
Further, the three major subpopulations of PBMC, i.e., mon- 
ocytes, B lymphocytes, and T lymphocytes, secreted approx- 
imately equivalent quantities of these molecules after pulse 
labeling with H2 3sSO4. Most of the sulfate-labeled material 
was  actively secreted from cells,  since <10%  of 35S counts 
were cell-associated after the 4-d culture period (Table III). 
Characterization of Sulfated PC 
We next evaluated the characteristics and types of sulfated 
material synthesized and secreted by human PBMC. Undi- 
gested, secreted material from both lymphocyte  and monocyte 
populations was completely soluble in water, distinguishing it 
from matrix-bound CSPG made by chondrocytes. It migrated 
in the  Vo of Sephadex G-50 and Sephacryl S-200 (Fig.  1). 
Chromatography on Sepharose 6B revealed a relatively poly- 
disperse molecule with a  Kay of 0.23  (Fig.  2).  This elution 
pattern was consistent with an approximate molecular weight 
of 130,000, according to the estimates of Kanwar et al. (26) 
for  similar  material  extracted  from  glomerular  basement 
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FIGURE  2  Migration of proteoglycans isolated from 
media of mononuclear leukocytes on Sepharose 6B. 
Proteoglycans  isolated from media of normal PBMC 
(O) or PBMC incubated with 4-methylumbelliferyl- 
B-D-xyloside  (O) were separated on a 1.5-cm x  50- 
cm  Sepharose  6B  column.  Material  migrating be- 
tween 25 and 43 ml were treated with 0.5 N NaOH, 
then rechromatographed on the same column (C3). 
Vo, void volume. Vt, total volume. 
,,o,2 
ro 
'0 
x 
o 
V0  Vt 
b 
.A 
I  I  I  I  I  I  I  I 
40  50  60  70  80  90  I00  I10  120  130 
Volume  (ml) 
FIGURE  3  Migration on Sephacryl S-200 of proteoglycans isolated 
from  the  cells  of  cultured  PBMC. Sulfate-labeled PBMCs were 
washed with 0.15  M  NaCI  then  lysed  with  NP-40-deoxycholate 
buffer.  Debris  was  removed  by  high  speed centrifugation. The 
supernatant was dialyzed against elution buffer, then separated on 
a 1-cm x  85-cm column of Sephacryl  S-200 NIL Material migrating 
between fractions 50 and 70 was treated with 0.5 N  NaOH, then 
rechromatographed on the same column (O). Vo, void volume. Vt, 
total volume. 
membrane. The elution patterns of PG were identical whether 
0.15 M NaC1 or 4 M guanidine HC1 were employed as solvent, 
indicating that proteoglycans were not secreted as aggregates 
that were dissociated at high salt concentrations. 
Sulfate-labeled molecules were extracted from washed cells 
after  lysis  with  detergent  buffer.  Following  centrifugation, 
soluble material was dialyzed against H20, lyophilized, then 
dissolved  in  either  0.15  M  NaC1  or  4  M  guanidine  HC1. 
Chromatography of this cell-associated PG on Sepharose 6B 
revealed a far more polydisperse pattern than its counterpart 
from medium; this 35S-labeled material migrated primarily in 
the  Vo of Sephacryl S-200 but could also be detected in the 
included fractions (Fig. 3). 
Since  water-soluble  macromolecules  that  can  be  pulse- 
labeled with H2 35SO4 are generally considered to be proteo- 
glycans (2),  we explored which specific PGs were produced 
and  secreted  by  PBMCs.  Large  molecular  weight  sulfate- 
labeled  material  collected  from  either  Sepharose  6B  or 
Sephacryl S-200 columns was treated with  HNO3 (41,  42); 
the  amount  of released  35S  constituted  the  percentage  of 
heparan sulfate in the sample. As shown in Fig. 4 and Table 
IV, <5% of 35S from the media of Con A-stimualted PBMC 
was detected in the V, of Sepharose 6B columns. The amount 
of chondroitin  4/6  sulfate and dermatan  sulfate was deter- 
mined by digesting the included material from 6B or S-200 
columns with  chondroitinase  AC or ABC  (44).  Fig.  4  and 
Table  IV demonstrate  that  an  average of 98%  of the  35S 
radioactivity appeared in the  Vt after chondroitinase AC or 
ABC treatment,  suggesting that virtually all of the  sulfated 
material was either chondroitin 4 or 6 sulfate. Sulfate-labeled 
material from media of unstimulated cultures of PBMC,  B 
cells,  or T  cells consisted of 75  chondroitin  4/6 sulfate and 
20% HNO3-sensitive heparan sulfate (Table IV). 
75-80% of 35S radioactivity was digested by chondroitin- 
ase  AC  in  material  isolated  from  cell  lysates  of Con  A- 
stimulated mononuclear leukocytes, indicating that most of 
the intracellular PG possessed chondroitin sulfate polysaccha- 
ride  chains.  Another  15-20%  of the  radioactivity was  de- 
graded after incubation with HNO3, demonstrating the pres- 
ence of heparan sulfate in mononuclear cells. Between 5 and 
10% of the sulfated material associated with cells could not 
be characterized and may be composed of sulfoglycoproteins. 
In cell lysates from unstimulated cultures, >90% of PG was 
heparan sulfate, chondroitin sulfate comprising only 5-10% 
of sulfate-labeled material (Table IV). 
To evaluate the size of chondroitin sulfate chains produced 
normally by PBMC and spleen cells,  CSPG from the  Vo of 
Sephadex G-50 was either digested for 8 h with nonspecific 
protease or treated with 0.5 N NaOH to release polysaccharide 
chains  from  o-serine  linkages.  Released  material  migrated 
with a K,v of 0.54 on Sepharose 6B (Fig.  2) and an approxi- 
mate molecular weight of 25,000, they were also included on 
Sephacryl S-200 columns (Figs.  1 and 3). As previously shown, 
chondroitin sulfate chains secreted by lymphocytes incubated 
with  ~-D-xylosides were  somewhat  shorter  than  chains  re- 
leased from normal proteoglycans and exhibited a molecular 
weight of  15,000  (Fig.  2).  Paper chromatography of chon- 
droitinase digests of 35S-labeled CSPG revealed that virtually 
all  of the  radioactivity migrated  identical  to  the  A-Di-4-S 
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duced by these immunocytes. 
Mitogens Stimulate T Lymphocytes to 5ecrete 
More CSPG 
We  evaluated  alterations  of CSPG  production  in  blood 
mononuclear cells treated with different "activators" to deter- 
mine whether consistent changes in either biosynthetic rates 
or patterns of this molecule occurred.  As shown in  Fig.  5, 
both  Con  A  and  tetraphorbol  acetate  (TPA)  induced  the 
greatest increase  in  CSPG secretion by PBMC  and  T  cells 
(Fig. 5 a and b). B cell populations were poorly stimulated to 
produce PG by any mitogen we used (Fig.  5 c) while mono- 
cytes were enhanced 1.5-2-fold by PWM and twofold by LPS 
(Fig.  5 d). No synergism between Con A and TPA for CSPG 
synthesis could be detected,  suggesting that both molecules 
may induce the same population of cells. 
The time and dose dependence of Con A-induced CSPG 
secretion by T  cells was also evaluated (Fig.  6).  A threefold 
increase in CSPG secretion was discernable by 3 d  in vitro. 
Although the absolute amount of CSPG in media increased 
over the next 2 d of culture, the relative degree of stimulation 
remained  approximately the  same.  To  determine  whether 
continued stimulation by Con A was required for enhanced 
PG secretion, PBMC were incubated with 25 #g/ml Con A 
for 3 d, then labeled for 24 h  in the presence or absence of 
Con A. A threefold decrease in the amount of CSPG secreted 
by cells labeled in the absence of Con A occurred (12,063 _+ 
355 cpm 35SO4 vs. 37,255  _  1,560 cpm 35504), suggesting that 
continued physical contact with the cell surface is necessary 
for Con A to exert its effect on CSPG production. 
The correlation between DNA synthesis and CSPG secre- 
tion induced by Con A was poor; while [3H]thymidine incor- 
poration generally displayed maximum activity at 5-10 ug/ 
ml Con A and decreased with higher doses of this mitogen, 
CSPG secretion was greatest when >10 ~g/ml were added to 
cultures and did not diminish at 50 ~g/ml Con A (Fig. 7). 
Mouse Spleen Cells Also Secrete CSPG 
Since responses of murine lymphocytes to various mitogens 
have been well characterized, we investigated production of 
CSPG by spleen cells from these animals. When cells from 
BALB/c mice were cultured and labeled with H2 35SO4, secre- 
tion of sulfated PG occurred rapidly. This material chromat- 
ographed identical  to CSPG  from human  PBMC  and  was 
degraded  by the  same enzymatic treatment;  therefore,  the 
sulfated PG produced by mouse lymphocytes was also chon- 
droitin sulfate proteoglycan. Spleen cells could be stimulated 
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FIGURE  4  Digestion of PG  by chondroi- 
tinase and HNO~. Sulfate-labeled PG iso- 
-4  lated  from  culture  media  of  PBMC  was 
separated on Sepharose 6B. Material mi- 
grating between 25  and  55  ml was con- 
-3  centrated and  treated with  either  HNO3 
(O) to assess the quantity of heparan sul- 
fate or with chondroitinase AC (r-I) to ana- 
-2  lyze chondroitin sulfate content.  Vo, void 
volume. Vt, total volume. 
TABLE IV 
Specific Degradation  of Sulfated Proteoglycans from Peripheral Blood Mononuclear Cells 
35  Percentage of  S-labeled Material 
Undigested* 
Media  Cells 
Treatment  U ~  S  s  U  S 
Digested* 
Media  Cells 
U  S  U  S 
HNO3 (for heparan sulfate)  80  96 
Chondroitinase ABC (for chrondroitin 4/6 sul-  25  2 
fates and dermatan sulfate) 
Chondroitinase AC (for chrondroitin 4/6 sulfates)  22  0.5 
19  73  20  4  81  27 
95  22  75  98  5  78 
93  20  78  99.5  7  80 
* Undigested = fractions 25-55 on Sepharose  6B column. 
* Digested = fractions 57-65 on Sepharose  6B column. 
s U, unstimulated cultures; S, cells stimulated with 25/~g/ml Con A. 
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nantly a T  cell mitogen, and not by LPS, a B cell activator 
(Table V); these findings were similar to the results from the 
human cultures. 
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FIGURE  5  Stimulation of  PG  secretion  by  lympohcyte activators. 
PBMCs or mononuclear cell subpopulations were incubated with 
various concentrations of activators and 25/~Ci/ml  H2 3sSO4. After 
4  d, culture media were harvested and  PG determined. The con- 
centrations of activators ultimately added to cultures were (a) Con 
A  =  25 ~.g/ml, (b) LPS =  50 ~g/ml,  (c) pwm =  1/400 (vol/vot), (d) 
PHA  =  25  #l/ml,  (e) SA =  1:8,000 (vol/vol), (f)  TPA =  10 ng/ml. 
Results  are  expressed  as  %  change  from  cultures  lacking  these 
activators. (a) PBMC. (b) T cells. (c) B cell population. (d) Adherent 
cells. 
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FIGURE  6  Dose and time course of Con A-stimulated PG secretion. 
106 cells were incubated with Con A at the indicated concentrations 
plus 25/~Ci/ml H23sso4. Cultures were harvested on d  1-5 and PG 
quantitated in culture media. 
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FIGURE  7  Proliferation vs.  PC  secretion  induced  by Con  A.  100 
PBMCs were stimulated with various concentrations of Con A. 25 
#Ci/ml H2 3sso4 or 5/~Ci/ml [3H]thymidine were added to cultures 
on day 0 and day 3  respectively. Cultures were harvested on day 
4; media were analyzed for PG secreted (0) and cells assessed  for 
thymidine incorporation into DNA (O). 
TABLE V 
Secretion of Sulfated Proteoglycans by Mouse Spleen Cells 
cpm 3sS secreted/lO  6 cells* 
Exp. no.  None  Con A  LPS 
1  7,350  37,225  9,730 
2  5,100  32,250  3,960 
3  10,090  49,330  7,150 
* 106 spleen cells/ml were cultured for 4 d with (a) no added stimuli,  (b) 5 
#g/ml Con A, or (c) 25/~g/ml LPS. Media were harvested and analyzed for 
sulfated proteoglycans as described in Materials and Methods. 
DISCUSSION 
Although chondroitin  sulfate proteoglycans are macromole- 
cules normally associated with cartilage, our results conclu- 
sively demonstrate that mononuclear cells from the immune 
systems of both  humans  and  mice  synthesize  and  secrete 
chondroitin sulfate linked to a core protein. However, there 
appear to  be  major  differences  between  the  two  types  of 
CSPG. The PG secreted by chondrocytes aggregates with link 
protein and hyaluronic acid to help form an insoluble matrix 
(3-5); it is a  large macromolecule with a  molecular weight 
between 2 and 3 million daltons (1, 2). The size of cartilage- 
specific  core  protein  has  been  estimated  to  be  200,000- 
300,000 daltons (45, 46). 
The CSPG derived  from lymphocytes and  monocytes is 
soluble in media, appears to be nonaggregated, and is ~  1/20 
the size of CSPG from cartilage. The CS chains are similar in 
size  to those found in  cartilage (54)  (25,000  daltons; range 
12-40,000 daltons) and preliminary gel filtration data suggest 
that the core protein is 30,000-35,000 daltons (D. Levitt and 
P.-L. Ho, unpublished observations). Thus, an average of  only 
four CS chains per core protein molecule would be expected, 
which  could  help  account  for  the  high  solubility  of this 
protein-polysaccharide complex. 
Chondroitin sulfate has been previously isolated from leu- 
kocytes obtained from human peripheral blood (6, 7) or rabbit 
bone marrow (8). In these studies, the quantities of CS, cells 
involved in  its  production,  size  of the  PG  molecule,  and 
secretion  of these  sulfated  polysaccharides were  not  deter- 
mined. Our findings indicate that CSPG is actively secreted 
by both lymphocytes and monocytes; after only a 24-h label- 
ing period, 90%  of incorporated 3sSO4 can be found in the 
culture media. Unstimulated culture supernatants contained 
both chondroitin 4-sulfate and heparan sulfate in a 3:1  ratio (based  upon  35SO4 incorporation).  After  stimulation  with 
either Con A  or TPA, the percentage of chondroitin sulfate 
increased to >90%  of the  isolated GAG.  Further,  heparan 
sulfate comprised >90% of the sulfated GAG from "resting" 
PBMC lysates and only 20% of sulfate-labeled material in cell 
lysates from stimulated cultures. Thus, the ratio of different 
types of sulfated GAG  vary in mononuclear leukocytes de- 
pending  upon  their  state  of activation.  Some  shedding  of 
heparan sulfate, a PG normally associated with the cell sur- 
face, (50-53)  occurs in vitro, but CSPG is the proteoglycan 
that is actively secreted by mononuclear leukocytes. Such cells 
may be responsible for producing the chondroitin-4 sulfate 
present in serum (27). 
Low molecular weight CSPG can be produced and secreted 
by noncartilage cells; many of these cells, however, are found 
primarily in connective tissues (10-15, 26, 43). Chondrocytes 
themselves appear to be capable of producing such low mo- 
lecular weight molecules, especially when expression of their 
differentiated  phenotype is  inhibited  (47).  It  is  not known 
how synthesis of this smaller PG is controlled. 
Our findings demonstrate that synthesis and secretion of 
CSPG can be modulated by at least two substances in PBMC, 
primarily in T lymphocytes. Both Con A and TPA stimulate 
two- to fivefold increases in CSPG secretion with the response 
to the stimuli occurring fairly rapidly. Each of these molecules 
effectively induces formation of interleukins, especially inter- 
leukin-2, by T  lymphocytes (48). The synthesis of these two 
molecules (CSPG  and interleukin-2) after induction by the 
same  compounds may  imply  a  functional  relationship.  In 
comparison to mononuclear leukocytes, our preliminary data 
(D.  Levitt,  L.  Wagner-Weiner,  and  P.-L.  Ho,  unpublished 
data) indicate that polymorphonuclear leukocytes synthesize 
and secrete similar amounts of PG  as mononuclear leuko- 
cytes; none of this material appears to be CSPG. Also, these 
cells are not stimulated to produce more PG by either the 
same compounds that enhance PG synthesis by PBMC, or by 
substances that alter polymorphonuclear leukocyte functions, 
a situation we are currently exploring. 
The  function  of sulfated  polysaccharides in  normal cell 
physiology or immune regulation is unknown. In the immune 
system, fractions of CSPG isolated from human cartilage may 
alter mitogenic responses of human PBMC to PHA (30). The 
nonsulfated GAG  hyaluronic acid  suppresses mitogenic re- 
sponses by immune lymphocytes (29,  49).  Heparan sulfate 
on the surface of normal and transformed cells may mediate 
intercellular interactions and cell growth (50-53).  As yet, no 
studies have evaluated the functional roles of secreted,  low 
molecular weight CSPGs.  It  seems reasonable that sulfated 
polyanions  could  electrostatically  bind  cationic  substances 
which are secreted by cells or are adherent to cell surfaces. In 
this way, the polyanions might serve as ligands that promote 
intercellular communications. The polyanionic CSPG might 
also interact with lymphocyte mediators and either protect 
them from proteolytic destruction or assist their association 
with  receptor  sites  on  target  cell  surfaces.  Since  we  have 
recently purified the soluble CSPG secreted by T  cells,  it is 
now possible to explore its effects on specific functions of the 
immune system. 
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